Atlas Trials

The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment

Clinical trial NCT05022186 · UNKNOWN

Trial details

NCT number
NCT05022186
Sponsor
Aristotle University Of Thessaloniki
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Mild Cognitive Impairment
Start date
2021-04-01
Primary completion
2022-12-20
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.